Development of cross-reactive antibodies to the proline-rich region of pneumococcal surface protein A in children

Vaccine

Volumn 30, Issue 50, 2012, Pages 7157-7160

  Melin, Merit ^a   Coan, Pat ^b   Hollingshead, Susan ^b  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b University of Alabama at Birmingham   (United States)

Author keywords

Antibody; Pneumococcal surface protein A; Pneumococcus; Proline rich region; PspA family; Streptococcus pneumoniae

Indexed keywords

CROSS REACTING ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; PNEUMOCOCCAL SURFACE PROTEIN A; PNEUMOCOCCAL SURFACE PROTEIN A PROLINE RICH REGION; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; BACTERIAL COLONIZATION; BLOOD SAMPLING; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; NASOPHARYNGEAL ASPIRATION; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; CHILD, PRESCHOOL; CROSS REACTIONS; HUMANS; IMMUNOGLOBULIN G; INFANT; STREPTOCOCCUS PNEUMONIAE;

EID: 84869883387     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.10.004     Document Type: Article

References (16)

1. Hollingshead S.K., Becker R., Briles D.E. Diversity of PspA: mosaic genes and evidence for past recombination in Streptococcus pneumoniae. Infect Immun 2000, 68(October (10)):5889-5900.
2. Yother J., Briles D.E. Structural properties and evolutionary relationships of PspA, a surface protein of Streptococcus pneumoniae, as revealed by sequence analysis. J Bacteriol 1992, 174(January (2)):601-609.
3. Yother J., White J.M. Novel surface attachment mechanism of the Streptococcus pneumoniae protein PspA. J Bacteriol 1994, 176(May (10)):2976-2985.
4. McDaniel L.S., Ralph B.A., McDaniel D.O., Briles D.E. Localization of protection-eliciting epitopes on PspA of Streptococcus pneumoniae between amino acid residues 192 and 260. Microb Pathog 1994, 17(November (5)):323-337.
5. Daniels C.C., Coan P., King J., Hale J., Benton K.A., Briles D.E., et al. The proline-rich region of pneumococcal surface proteins A and C contains surface-accessible epitopes common to all pneumococci and elicits antibody-mediated protection against sepsis. Infect Immun 2010, 78(May (5)):2163-2172.
6. Brooks-Walter A., Briles D.E., Hollingshead S.K. The pspC gene of Streptococcus pneumoniae encodes a polymorphic protein, PspC, which elicits cross-reactive antibodies to PspA and provides immunity to pneumococcal bacteremia. Infect Immun 1999, 67(December (12)):6533-6542.
7. Iannelli F., Oggioni M.R., Pozzi G. Allelic variation in the highly polymorphic locus pspC of Streptococcus pneumoniae. Gene 2002, 284(February (1-2)):63-71.
8. Giefing C., Meinke A.L., Hanner M., Henics T., Bui M.D., Gelbmann D., et al. Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies. J Exp Med 2008, 205(January (1)):117-131.
9. Meinke A., Henics T., Hanner M., Minh D.B., Nagy E. Antigenome technology: a novel approach for the selection of bacterial vaccine candidate antigens. Vaccine 2005, 23(March (17-18)):2035-2041.
10. Melin M.M., Hollingshead S.K., Briles D.E., Lahdenkari M.I., Kilpi T.M., Käyhty H.M. Development of antibodies to PspA families 1 and 2 in children after exposure to Streptococcus pneumoniae. Clini Vaccine Immunol 2008, 15(October (10)):1529-1535.
11. Melin M.M., Hollingshead S.K., Briles D.E., Hanage W.P., Lahdenkari M., Kaijalainen T., et al. Distribution of pneumococcal surface protein A families 1 and 2 among Streptococcus pneumoniae isolates from children in finland who had acute otitis media or were nasopharyngeal carriers. Clin Vaccine Immunol 2008, 15(October (10)):1555-1563.
12. Syrjänen R.K., Kilpi T.M., Kaijalainen T.H., Herva E.E., Takala A.K. Nasopharyngeal carriage of Streptococcus pneumoniae in Finnish children younger than 2 years old. J Infect Dis 2001, 184(August (4)):451-459.
13. Kilpi T., Herva E., Kaijalainen T., Syrjanen R., Takala A.K. Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life. Pediatr Infect Dis J 2001, 20(July (7)):654-662.
14. Simell B., Melin M., Lahdenkari M., Briles D.E., Hollingshead S.K., Kilpi T.M., et al. Antibodies to pneumococcal surface protein A families 1 and 2 in serum and saliva of children and the risk of pneumococcal acute otitis media. J Infect Dis 2007, 196(November (10)):1528-1536.
15. Nabors G.S., Braun P.A., Herrmann D.J., Heise M.L., Pyle D.J., Gravenstein S., et al. Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules. Vaccine 2000, 18(March (17)):1743-1754.
16. Jedrzejas M.J., Hollingshead S.K., Lebowitz J., Chantalat L., Briles D.E., Lamani E. Production and characterization of the functional fragment of pneumococcal surface protein A. Arch Biochem Biophys 2000, 373(Jan (1)):116-125.